ArteraAI and GenesisCare Partner to Provide Precision Cancer Therapy to Patients with Localized Prostate Cancer In Australia
Patients treated at GenesisCare clinics in Australia can work with clinicians to access AI-based decision making tools as part of a new clinical trial SAN FRANCISCO & SYDNEY–(BUSINESS WIRE)–ArteraAI, the developer of multimodal artificial intelligence (MMAI)-based predictive and prognostic cancer tests, and GenesisCare, one of the leading integrated cancer care providers in Australia, today announced … Read more